Author:
Nishida Yayoi,Takahashi Yasuo,Tezuka Kotoe,Takeuchi Satoshi,Nakayama Tomohiro,Asai Satoshi
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Kidney Disease Outcomes Quality Initiative (K, DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5 Suppl 1):S1–290.
2. Kidney Disease: Improving Global Outcomes (KDIGO) Management of Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2012;2(5):337–414.
3. Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH2014). Hypertens Res. 2014;37(4):253–390.
4. Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Ca2+ channel subtypes and pharmacology in the kidney. Circ Res. 2007;100(3):342–53.
5. Hayashi K, Homma K, Wakino S, Tokuyama H, Sugano N, Saruta T, et al. T-type Ca channel blockade as a determinant of kidney protection. Keio J Med. 2010;59(3):84–95.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献